Retinal lesions and potential confounders in mouse models / 中华实验眼科杂志

During the application of spontaneous or genetically engineered mouse models for retinal diseases,some phenotypes of the models might not be related to the gene (s) of interest or intentional manipulation.This problem often arises from founder effect of inbreed mouse strains.The most impact experiences in vision research community are mouse models incorporated with mutations in Crb1 (rd8),phosphodiesterase 6 beta (Pde6b) (rd1),Gnat2 and RPE65 genes.This paper reviewed the most relevant articles on this matter.We encourage that vision researchers who apply or develop mouse lines to study retinal diseases should carefully track and check the genetic background of their stains and/or choose proper controls in the study design.

Mycobacterium-related ocular inflammatory disease: diagnosis and management

<p><b>INTRODUCTION</b>Worldwide, there are approximately 8 million new cases and 3 million deaths from tuberculosis (TB) each year. TB affects the entire body and the eye. Although ocular TB is considered rare, its incidence has varied widely across time, patient populations, and geography. We report 2 patients with unique presentations of ocular TB and detail the treatment and outcome of the disease.</p><p><b>MATERIALS AND METHODS</b>Two cases of ocular inflammation, one with a medical history of systemic TB and the other, with that of presumed systemic TB, were examined. Choroidal granuloma developed in one, and scleritis developed in the other. The literature on ocular TB was comprehensively reviewed.</p><p><b>RESULTS</b>Both patients were diagnosed with ocular TB. The histology of the systemic TB lesions was also illustrated. They responded to aggressive anti- TB and anti-inflammatory therapies.</p><p><b>CONCLUSIONS</b>The diagnosis and management of ocular TB can pose a significant challenge. Physicians and ophthalmologists must include TB among the differential diagnoses of patients with ocular inflammatory diseases and treat ocular TB with a combination of anti-TB and immunosuppressive medications as needed. Immunosuppressive medications applied in this setting must be cautioned and only prescribed by ophthalmologists who are familiar with these agents.</p>